HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

IMC1C11

chimeric anti-kinase insert domain-containing receptor (KDR) antibody that blocks VEGFR-KDR interaction and inhibits VEGFR-induced endothelial cell proliferation; used for treatment of patients with liver metastases from colorectal carcinoma (in Phase I trial 1/2004)
Also Known As:
IMC-1C11
Networked: 4 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Dias, S: 2 articles (03/2003 - 08/2000)
2. Hattori, K: 2 articles (03/2003 - 08/2000)
3. Zhu, Z: 2 articles (03/2003 - 08/2000)
4. Rafii, S: 2 articles (03/2003 - 08/2000)
5. Witte, L: 2 articles (03/2003 - 08/2000)
6. Moore, Malcolm A S: 1 article (11/2004)
7. Teruya-Feldstein, Julie: 1 article (11/2004)
8. Hicklin, Daniel J: 1 article (11/2004)
9. Zhu, Zhenping: 1 article (11/2004)
10. Wang, Eunice S: 1 article (11/2004)

Related Diseases

1. Colorectal Neoplasms (Colorectal Cancer)
2. Neoplasm Metastasis (Metastasis)
3. Leukemia
4. Neoplasms (Cancer)

Related Drugs and Biologics

1. Phosphotransferases (Kinase)
2. Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)

Related Therapies and Procedures

1. Heterologous Transplantation (Xenotransplantation)